{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:08:53Z","timestamp":1721174933360},"reference-count":39,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.20945\/2359-3997000000120","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T20:18:51Z","timestamp":1553285931000},"source":"Crossref","is-referenced-by-count":6,"title":["Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case series"],"prefix":"10.20945","author":[{"given":"Danielle","family":"Pess\u00f4a-Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateus Fernandes da Silva","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virna Mendon\u00e7a Sampaio","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Joaquim Cust\u00f3dio da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ta\u00edse Lima de Oliveira","family":"Cerqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor Campos da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Luciano Espinheira","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Jos\u00e9 Lob\u00e3o","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udio Rog\u00e9rio Alves de","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helton Estrela","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"key20190701145840_B1","doi-asserted-by":"crossref","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Bray","year":"2018","unstructured":"1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018.","journal-title":"CA Cancer J Clin."},{"issue":"13","key":"key20190701145840_B2","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974--2013","volume":"317","author":"Lim","year":"2017","unstructured":"2. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974--2013. JAMA. 2017;317(13):1338-48.","journal-title":"JAMA"},{"key":"key20190701145840_B3","volume-title":"SEER Cancer Statistics Review, 1975-2015","author":"Noone","unstructured":"3. Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, et al. (eds.). SEER Cancer Statistics Review, 1975-2015. Bethesda, MD. National Cancer Institute. Available from: https:\/\/seer.cancer.gov\/csr\/1975_2015\/."},{"issue":"10","key":"key20190701145840_B4","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.4158\/EP171924.OR","article-title":"Long-term outcomes and prognostic factors in patients with differentiated thyroid cancer and distant metastases","volume":"23","author":"Hirsch","year":"2017","unstructured":"4. Hirsch D, Levy S, Tsvetov G, Gorshtein A, Slutzky-Shraga I, Akirov A, et al. Long-term outcomes and prognostic factors in patients with differentiated thyroid cancer and distant metastases. Endocr Pract. 2017;23(10):1193-200.","journal-title":"Endocr Pract."},{"issue":"4","key":"key20190701145840_B5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1590\/S0004-27302013000400002","article-title":"Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus","volume":"57","author":"Ros\u00e1rio","year":"2013","unstructured":"5. Ros\u00e1rio PW, Ward LS, Carvalho GA, Graf H, Maciel RM, Maciel LM, et al.; Sociedade Brasileira de Endocrinologia e Metabologia. Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus. Arq Bras Endocrinol Metabol. 2013;57(4):240-64.","journal-title":"Arq Bras Endocrinol Metabol."},{"issue":"1","key":"key20190701145840_B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","unstructured":"6. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133.","journal-title":"Thyroid"},{"issue":"1","key":"key20190701145840_B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CCO.0000000000000022","article-title":"New insights in risk stratification of differentiated thyroid cancer","volume":"26","author":"Papaleontiou","year":"2014","unstructured":"7. Papaleontiou M, Haymart MR. New insights in risk stratification of differentiated thyroid cancer. Curr Opin Oncol. 2014;26(1):1-7.","journal-title":"Curr Opin Oncol."},{"issue":"7","key":"key20190701145840_B8","first-page":"1454","article-title":"High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma","volume":"63","author":"Kimura","year":"2003","unstructured":"8. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 2003;63(7):1454-7.","journal-title":"Cancer Res."},{"issue":"7","key":"key20190701145840_B9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/er.2007-0007","article-title":"BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications","volume":"28","author":"Xing","year":"2007","unstructured":"9. Xing M. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev. 2007;28(7):742-62.","journal-title":"Endocr Rev."},{"issue":"5","key":"key20190701145840_B10","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ijc.28976","article-title":"Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma","volume":"137","author":"Gandolfi","year":"2015","unstructured":"10. Gandolfi G, Sancisi V, Piana S, Ciarrocchi A. Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma. Int J Cancer. 2015;137(5):1001-11.","journal-title":"Int J Cancer"},{"issue":"7","key":"key20190701145840_B11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/thy.2014.0460","article-title":"Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer","volume":"25","author":"Francis","year":"2015","unstructured":"11. Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, et al.; American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015;25(7):716-59.","journal-title":"Thyroid"},{"issue":"12","key":"key20190701145840_B12","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1210\/jc.2012-2104","article-title":"BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis","volume":"97","author":"Li","year":"2012","unstructured":"12. Li C, Lee KC, Schneider EB, Zeiger MA. BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis. J Clin Endocrinol Metab. 2012;97(12):4559-70.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20190701145840_B13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12957-016-0979-1","article-title":"Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis","volume":"14","author":"Liu","year":"2016","unstructured":"13. Liu C, Chen T, Liu Z. Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis. World J Surg Oncol. 2016;14(1):241.","journal-title":"World J Surg Oncol"},{"issue":"5","key":"key20190701145840_B14","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/cncr.24118","article-title":"High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes","volume":"115","author":"Oler","year":"2009","unstructured":"14. Oler G, Cerutti JM. High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes. Cancer. 2009;115(5):972-80.","journal-title":"Cancer"},{"issue":"8","key":"key20190701145840_B15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.prp.2012.05.013","article-title":"mRNA BRAF expression helps to identify papillary thyroid carcinomas in thyroid nodules independently of the presence of BRAFV600E mutation","volume":"208","author":"Araujo","year":"2012","unstructured":"15. Araujo PP, Marcello MA, Tincani AJ, Guilhen AC, Morari EC, Ward LS. mRNA BRAF expression helps to identify papillary thyroid carcinomas in thyroid nodules independently of the presence of BRAFV600E mutation. Pathol Res Pract. 2012;208(8):489-92.","journal-title":"Pathol Res Pract"},{"issue":"12","key":"key20190701145840_B16","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1089\/thy.2012.0304","article-title":"BRAF: a tool in the decision to perform elective neck dissection?","volume":"23","author":"Dutenhefner","year":"2013","unstructured":"16. Dutenhefner SE, Marui S, Santos AB, de Lima EU, Inoue M, Neto JS, et al. BRAF: a tool in the decision to perform elective neck dissection? Thyroid. 2013;23(12):1541-6.","journal-title":"Thyroid"},{"issue":"3","key":"key20190701145840_B17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12020-018-1642-0","article-title":"TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma","volume":"61","author":"Penna","year":"2018","unstructured":"17. Penna GC, Pestana A, Cameselle JM, Momesso D, de Andrade FA, Vidal APA, et al. TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma. Endocrine. 2018;61(3):489-98.","journal-title":"Endocrine"},{"issue":"3","key":"key20190701145840_B18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12022-018-9526-7","article-title":"LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases","volume":"29","author":"Pinheiro Dos Santos","year":"2018","unstructured":"18. Pinheiro Dos Santos MJC, Bastos AU, da Costa VR, Delcelo R, Lindsey SC, Colozza-Gama GA, et al. LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases. Endocr Pathol. 2018;29(3):222-30.","journal-title":"Endocr Pathol"},{"issue":"2","key":"key20190701145840_B19","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.4238\/2015.May.12.9","article-title":"BRAF overexpression is associated with BRAF V600E mutation in papillary thyroid carcinomas","volume":"14","author":"da Silva","year":"2015","unstructured":"19. da Silva RC, de Paula HS, Leal CB, Cunha BC, de Paula EC, Alencar RC, et al. BRAF overexpression is associated with BRAF V600E mutation in papillary thyroid carcinomas. Genet Mol Res. 2015;14(2):5065-75.","journal-title":"Genet Mol Res"},{"key":"key20190701145840_B20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mce.2017.12.004","article-title":"Imbalance in DNA repair machinery is associated with BRAFV600E mutation and tumour aggressiveness in papillary thyroid carcinoma","volume":"472","author":"Lutz","year":"2018","unstructured":"20. Lutz BS, Leguisamo NM, Cabral NK, Gloria HC, Reiter KC, Agnes G, et al. Imbalance in DNA repair machinery is associated with BRAFV600E mutation and tumour aggressiveness in papillary thyroid carcinoma. Mol Cell Endocrinol. 2018;472:140-8.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"key20190701145840_B21","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00394-016-1370-2","article-title":"Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area","volume":"57","author":"Kim","year":"2018","unstructured":"21. Kim HJ, Park HK, Byun DW, Suh K, Yoo MH, Min YK, et al. Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area. Eur J Nutr. 2018;57(2):809-15.","journal-title":"Eur J Nutr"},{"issue":"7","key":"key20190701145840_B22","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1089\/thy.2015.0448","article-title":"Iodine Nutritional Status in Schoolchildren from Public Schools in Brazil: A Cross-Sectional Study Exposes Association with Socioeconomic Factors and Food Insecurity","volume":"26","author":"Campos Rde","year":"2016","unstructured":"22. Campos Rde O, Reboucas SC, Beck R, de Jesus LR, Ramos YR, Barreto Idos S, et al. Iodine Nutritional Status in Schoolchildren from Public Schools in Brazil: A Cross-Sectional Study Exposes Association with Socioeconomic Factors and Food Insecurity. Thyroid. 2016;26(7):972-9.","journal-title":"Thyroid"},{"issue":"6","key":"key20190701145840_B23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1089\/thy.2012.0532","article-title":"Thyroid cancer incidence patterns in S\u00e3o Paulo, Brazil, and the U.S SEER program, 1997-2008","volume":"23","author":"Veiga","year":"2013","unstructured":"23. Veiga LH, Neta G, Aschebrook-Kilfoy B, Ron E, Devesa SS. Thyroid cancer incidence patterns in S\u00e3o Paulo, Brazil, and the U.S SEER program, 1997-2008. Thyroid. 2013;23(6):748-57.","journal-title":"Thyroid."},{"issue":"2","key":"key20190701145840_B24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1507\/endocrj.K08E-166","article-title":"Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid","volume":"56","author":"Ito","year":"2009","unstructured":"24. Ito Y, Miyauchi A. Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J. 2009;56(2):177-92.","journal-title":"Endocr J"},{"issue":"5","key":"key20190701145840_B25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1200\/JCO.2017.74.5497","article-title":"Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer","volume":"36","author":"Shen","year":"2018","unstructured":"25. Shen X, Zhu G, Liu R, Viola D, Elisei R, Puxeddu E, et al. Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer. J Clin Oncol. 2018;36(5):438-45.","journal-title":"J Clin Oncol"},{"key":"key20190701145840_B26","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/845362","article-title":"Thyroid carcinoma in children and adolescents-systematic review of the literature","volume":"2011","author":"Vaisman","year":"2011","unstructured":"26. Vaisman F, Corbo R, Vaisman M. Thyroid carcinoma in children and adolescents-systematic review of the literature. J Thyroid Res. 2011;2011:845362.","journal-title":"J Thyroid Res"},{"issue":"1","key":"key20190701145840_B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2003.12.004","article-title":"Low prevalence of BRAF mutations in radiation-induced thyroid tumours in contrast to sporadic papillary carcinomas","volume":"209","author":"Nikiforova","year":"2004","unstructured":"27. Nikiforova MN, Ciampi R, Salvatore G, Santoro M, Gandhi M, Knauf JA, et al. Low prevalence of BRAF mutations in radiation-induced thyroid tumours in contrast to sporadic papillary carcinomas. Cancer Lett. 2004;209(1):1-6.","journal-title":"Cancer Lett"},{"issue":"4","key":"key20190701145840_B28","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1158\/1078-0432.CCR-06-1753","article-title":"Suppression of BRAF\/MEK\/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant","volume":"13","author":"Liu","year":"2007","unstructured":"28. Liu D, Hu S, Hou P, Jiang D, Condouris S, Xing M. Suppression of BRAF\/MEK\/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant. Clin Cancer Res. 2007;13(4):1341-9.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"key20190701145840_B29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF03401282","article-title":"Hashimoto's thyroiditis: history and future outlook","volume":"12","author":"Hiromatsu","year":"2013","unstructured":"29. Hiromatsu Y, Satoh H, Amino N. Hashimoto's thyroiditis: history and future outlook. Hormones (Athens). 2013;12(1):12-8.","journal-title":"Hormones (Athens)"},{"issue":"5","key":"key20190701145840_B30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","unstructured":"30. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74.","journal-title":"Cell"},{"issue":"7","key":"key20190701145840_B31","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","unstructured":"31. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073-81.","journal-title":"Carcinogenesis"},{"issue":"29","key":"key20190701145840_B32","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1038\/sj.onc.1206759","article-title":"Tyrosine kinase oncoprotein, RET\/PTC3, induces the secretion of myeloid growth and chemotactic factors","volume":"22","author":"Russell","year":"2003","unstructured":"32. Russell JP, Shinohara S, Melillo RM, Castellone MD, Santoro M, Rothstein JL. Tyrosine kinase oncoprotein, RET\/PTC3, induces the secretion of myeloid growth and chemotactic factors. Oncogene. 2003;22(29):4569-77.","journal-title":"Oncogene"},{"issue":"41","key":"key20190701145840_B33","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1073\/pnas.0503039102","article-title":"Induction of a proinflammatory program in normal human thyrocytes by the RET\/PTC1 oncogene","volume":"102","author":"Borrello","year":"2005","unstructured":"33. Borrello MG, Alberti L, Fischer A, Degl'innocenti D, Ferrario C, Gariboldi M, et al. Induction of a proinflammatory program in normal human thyrocytes by the RET\/PTC1 oncogene. Proc Natl Acad Sci U S A. 2005;102(41):14825-30.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20190701145840_B34","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.12659\/MSM.904928","article-title":"BRAF (V600E) and RET\/PTC Promote Proliferation and Migration of Papillary Thyroid Carcinoma Cells In Vitro by Regulating Nuclear Factor-\u03baB","volume":"23","author":"Zhou","year":"2017","unstructured":"34. Zhou D, Li Z, Bai X. BRAF (V600E) and RET\/PTC Promote Proliferation and Migration of Papillary Thyroid Carcinoma Cells In Vitro by Regulating Nuclear Factor-\u03baB. Med Sci Monit. 2017;23:5321-9.","journal-title":"Med Sci Monit"},{"issue":"5","key":"key20190701145840_B35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2265.2009.03699.x","article-title":"The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies","volume":"72","author":"Muzza","year":"2010","unstructured":"35. Muzza M, Degl'Innocenti D, Colombo C, Perrino M, Ravasi E, Rossi S, et al. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf). 2010;72(5):702-8.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"key20190701145840_B36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/cen.12194","article-title":"BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present","volume":"79","author":"Marotta","year":"2013","unstructured":"36. Marotta V, Guerra A, Zatelli MC, Uberti ED, Di Stasi V, Faggiano A, et al. BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present. Clin Endocrinol (Oxf). 2013;79(5):733-8.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"key20190701145840_B37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/thy.2017.0102","article-title":"Updated American Joint Committee on Cancer\/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?","volume":"27","author":"Tuttle","year":"2017","unstructured":"37. Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on Cancer\/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? Thyroid. 2017;27(6):751-6.","journal-title":"Thyroid"},{"issue":"11","key":"key20190701145840_B38","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cncr.21073","article-title":"Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations","volume":"103","author":"Quiros","year":"2005","unstructured":"38. Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer. 2005;103(11):2261-8.","journal-title":"Cancer"},{"issue":"6","key":"key20190701145840_B39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/ERC-11-0212","article-title":"Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells","volume":"18","author":"Hou","year":"2011","unstructured":"39. Hou P, Liu D, Xing M. Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells. Endocr Relat Cancer. 2011;18(6):687-97.","journal-title":"Endocr Relat Cancer"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T02:18:02Z","timestamp":1721096282000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972019000200097&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":39,"alternative-id":["10.20945\/2359-3997000000120"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000120","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]}}}